These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3239479)

  • 41. The menstrual cycle in women using an intrauterine device.
    Faundes A; Segal SJ; Adejuwon CA; Brache V; Leon P; Alvarez-Sanchez F
    Fertil Steril; 1980 Nov; 34(5):427-30. PubMed ID: 7439408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of intrauterine contraceptive devices on cytokine messenger ribonucleic acid expression in the human endometrium.
    Ammälä M; Nyman T; Strengell L; Rutanen EM
    Fertil Steril; 1995 Apr; 63(4):773-8. PubMed ID: 7890061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Five years' experience with levonorgestrel-releasing IUDs.
    Luukkainen T; Allonen H; Haukkamaa M; Lähteenmäki P; Nilsson CG; Toivonen J
    Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New observations in the sonographic evaluation of intrauterine contraceptive devices.
    Najarian KE; Kurtz AB
    J Ultrasound Med; 1986 Apr; 5(4):205-10. PubMed ID: 3514951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of leukaemia inhibitory factor (LIF) during the window of implantation in copper T380A intrauterine device users.
    Güney M; Oral B; Karahan N; Mungan T
    Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):212-9. PubMed ID: 17763259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased endometrial HOXA10 expression associated with use of the copper intrauterine device.
    Tetrault AM; Richman SM; Fei X; Taylor HS
    Fertil Steril; 2009 Dec; 92(6):1820-4. PubMed ID: 18930214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ultrastructure responses of human endometrium to inert and copper IUDs as viewed by scanning electron microscopy.
    El-badrawi HH; Hafez ES; Fayad M; Shafeek A
    Contracept Deliv Syst; 1980 Apr; 1(2):103-11. PubMed ID: 12336235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The mechanism of action of the copper intrauterine device.
    Tamaya T; Nakata Y; Ohno Y; Nioka S; Furuta N
    Fertil Steril; 1976 Jul; 27(7):767-72. PubMed ID: 181276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Copper determination and localization in different morphologic components of human endometrium during the menstrual cycle in copper intrauterine contraceptive device wearers.
    Salaverry G; Méndez Mdel C; Zipper J; Medel M
    Am J Obstet Gynecol; 1973 Jan; 115(2):163-8. PubMed ID: 4570954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanism of action of IUDs: an ultrastructural view.
    El-badrawi HH; Hafez ES
    Contracept Deliv Syst; 1981 Jul; 2(3):201-17. PubMed ID: 12278906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T.
    Andersson K; Batar I; Rybo G
    Contraception; 1992 Dec; 46(6):575-84. PubMed ID: 1493717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of Intrauterine Devices in Mares: A Histomorphological and Immunohistochemical Evaluation of the Endometrium.
    Klein V; Müller K; Schoon HA; Reilas T; Rivera del Alamo MM; Katila T
    Reprod Domest Anim; 2016 Feb; 51(1):98-104. PubMed ID: 26661561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Return of fertility after use of IUDs (Nova-T, MLCu250 and MLCu375).
    Skjeldestad FE; Bratt H
    Adv Contracept; 1987 Jun; 3(2):139-45. PubMed ID: 3630823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of intrauterine contraceptive devices on the ultrastructure of the endometrium in relation to bleeding complications.
    Sheppard BL; Bonnar J
    Am J Obstet Gynecol; 1983 Aug; 146(7):829-39. PubMed ID: 6869454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Five years' experience of intrauterine contraception with the Nova-T and the Copper-T-200.
    Luukkainen T; Allonen H; Nielsen NC; Nygren KG; Pyörälä T
    Am J Obstet Gynecol; 1983 Dec; 147(8):885-92. PubMed ID: 6650625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The intrauterine device today.
    Rioux JE
    J SOGC; 1993 Oct; 15(8):921-4. PubMed ID: 12318529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparative study of the ease of removal of intrauterine contraceptive devices.
    Roke CM
    Contraception; 1988 Jun; 37(6):555-63. PubMed ID: 3396356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two-year rates for Nova T and Copper T in a comparative study.
    Allonen H; Luukkainen T; Nielsen NC; Nygren KG; Pyörälä T
    Contraception; 1980 Apr; 21(4):321-34. PubMed ID: 6993095
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intrauterine device and maternal copper metabolism during lactation.
    Rodrigues da Cunha AC; Dorea JG; Cantuaria AA
    Contraception; 2001 Jan; 63(1):37-9. PubMed ID: 11257247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.